(D-Lys³)-GHRP-6

From WikiMD's WELLNESSPEDIA

(D-Lys³)-GHRP-6

(D-Lys³)-GHRP-6 is a synthetic peptide and a potent growth hormone secretagogue. It is a modified analog of the growth hormone-releasing peptide 6 (GHRP-6), where the third amino acid, lysine, is in the D-configuration. This modification enhances its biological activity and stability.

Structure and Function[edit]

(D-Lys³)-GHRP-6 is a hexapeptide with the sequence H-D-Lys-Ala-D-β-Nal-Ala-Trp-D-Phe-Lys-NH₂. The presence of D-Lysine at the third position is crucial for its enhanced activity compared to the natural L-form. This peptide acts on the pituitary gland to stimulate the release of growth hormone (GH), which plays a vital role in growth, metabolism, and body composition.

Mechanism of Action[edit]

(D-Lys³)-GHRP-6 binds to the growth hormone secretagogue receptor (GHS-R), a G-protein coupled receptor, which is distinct from the growth hormone-releasing hormone receptor. Upon binding, it activates intracellular signaling pathways that lead to the secretion of growth hormone from the anterior pituitary gland. This action is independent of the hypothalamic growth hormone-releasing hormone (GHRH) pathway.

Clinical Applications[edit]

While (D-Lys³)-GHRP-6 itself is primarily used in research settings, its mechanism of action has implications for treating conditions associated with growth hormone deficiency. It is studied for potential applications in:

  • Growth Hormone Deficiency: As a potential therapeutic agent to stimulate endogenous GH production.
  • Cachexia and Muscle Wasting: To counteract muscle loss in chronic diseases.
  • Aging: Investigated for its potential to mitigate age-related decline in GH levels.

Research and Development[edit]

Research on (D-Lys³)-GHRP-6 is ongoing to better understand its pharmacokinetics, efficacy, and safety profile. Animal studies have shown promising results, but more clinical trials are needed to establish its therapeutic potential in humans.

Side Effects and Safety[edit]

Potential side effects of (D-Lys³)-GHRP-6, similar to other GH secretagogues, may include:

  • Increased Appetite: Due to its ghrelin-mimetic effects.
  • Hyperglycemia: As a result of increased GH levels.
  • Joint Pain: Due to fluid retention and increased tissue growth.

Also see[edit]



This peptide related article is a stub. You can help WikiMD by expanding it.

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.

Retrieved from "https://wikimd.org/index.php?title=(D-Lys³)-GHRP-6&oldid=6021510"